Literature DB >> 30183984

Hypertension and Exercise: A Search for Mechanisms.

Bertha F Polegato1, Sergio A R de Paiva1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30183984      PMCID: PMC6122912          DOI: 10.5935/abc.20180146

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
Arterial hypertension is a chronic disease that affects approximately 40% of the population, with higher incidence at older ages.[1] Arterial hypertension is a risk factor for other cardiovascular diseases, such as heart failure, stroke, atherosclerosis and also chronic renal disease. It is estimated that more than 50% of deaths from coronary diseases and stroke occur in hypertensive patients;[2] for this reason, hypertension produces high costs in health and constitutes a public health problem.[3] In this context, the development of nonpharmacological therapies is a cost-effective strategy with few side effects, that helps in the prevention of comorbidities, such as diabetes and obesity, and increases the cardiovascular risk of the patient. Among nonpharmacological strategies, physical exercise deserves consideration. Rodrigues et al.,[4] in the study published in this issue of Arquivos Brasileiros de Cardiologia, evaluated the effect of moderate aerobic exercise on a treadmill in spontaneously hypertensive rats. The animals ran at 18-22m/min for 60 minutes, five times a week, for eight weeks.[4] The study confirmed the anti-hypertensive effects of aerobic exercise, as already reported previously.[5] More recently, other types of exercise in addition to aerobic training, such as resistance and interval training, have been shown to be promising in preventing hypertension.[6] Prescription of physical exercise for the treatment and prevention of hypertension is well established, and more recent guidelines for the treatment of hypertension strongly recommend exercise as a therapeutic option.[1],[2] Even though no doubt remains about the importance of physical exercise for the management of hypertension, the mechanisms of the beneficial effects have not been fully elucidated. In this regard, the study by Rodrigues et al.[4] proposed to investigate the transient concentration of intracellular calcium as well as the expression of microRNA (miRNA)-214, which is related to regulation of intracellular calcium and Serca-2a expression. The authors observed that physical exercise, in the presence of hypertension, increased the amplitude and decreased decay time of cytosolic calcium, which may suggest a higher availability of intracellular calcium, faster removal of this ion from the cytosol, and consequently, increased cellular relaxation. These results contribute to the understating of biological processes induced by exercises in the cardiomyocytes. Another interesting result of the study by Rodrigues et al.[4] was that non-hypertensive animals that underwent exercise training did not have any change in miRNA-214 expression whereas hypertensive animals that underwent training showed higher expression of this miRNA. MiRNAs are small RNA fragments that do not encode proteins, and negatively regulate gene expression at a post-transcriptional level. When discovered, miRNAs were believed to be non-functional sequences; however, since the 90’s decade, the interest in these molecules has grown and today is known to be involved in the regulation of important biological processes, including physiological and pathological ones.[7] In hypertension, clinical and experimental studies have identified many miRNAs that may be related to the hypertension and its complications,[8] emerging as possible biological markers and therapeutic targets in hypertension.[9] MiRNAs constitute a complex biological control network – one miRNA can have multiple genes as targets, while one gene can be regulated by many miRNAs.[10] So far, all possible interactions between miRNAs involved in a signaling pathway, as well as the regulatory mechanisms of miRNA functions are unknown. Maybe a miRNA expression panel is a stronger determinant than the expression of one unique miRNA in disease conditions. Despite these uncertainties, the promising role of miRNAs for the future of medicine is unquestionable, be it as a biomarker or as a therapeutic target. Despite the results of this study, the underlying mechanisms of the beneficial effect of exercise still need to be elucidated.
  9 in total

Review 1.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

2.  Aerobic exercise reduces blood pressure in resistant hypertension.

Authors:  Fernando Dimeo; Nikolaos Pagonas; Felix Seibert; Robert Arndt; Walter Zidek; Timm H Westhoff
Journal:  Hypertension       Date:  2012-07-16       Impact factor: 10.190

Review 3.  The role of miR-214 in cardiovascular diseases.

Authors:  Yanfang Zhao; Murugavel Ponnusamy; Lei Zhang; Yuan Zhang; Cuiyun Liu; Wanpeng Yu; Kun Wang; Peifeng Li
Journal:  Eur J Pharmacol       Date:  2017-08-24       Impact factor: 4.432

4.  10-Year Resource Utilization and Costs for Cardiovascular Care.

Authors:  Leslee J Shaw; Abhinav Goyal; Christina Mehta; Joe Xie; Lawrence Phillips; Anita Kelkar; Joseph Knapper; Daniel S Berman; Khurram Nasir; Emir Veledar; Michael J Blaha; Roger Blumenthal; James K Min; Reza Fazel; Peter W F Wilson; Matthew J Budoff
Journal:  J Am Coll Cardiol       Date:  2018-03-13       Impact factor: 24.094

Review 5.  Exercise and cardiovascular risk in patients with hypertension.

Authors:  James E Sharman; Andre La Gerche; Jeff S Coombes
Journal:  Am J Hypertens       Date:  2014-10-10       Impact factor: 2.689

Review 6.  Circulating microRNAs and hypertension--from new insights into blood pressure regulation to biomarkers of cardiovascular risk.

Authors:  Simon P R Romaine; Fadi J Charchar; Nilesh J Samani; Maciej Tomaszewski
Journal:  Curr Opin Pharmacol       Date:  2016-01-28       Impact factor: 5.547

Review 7.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

Review 8.  Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Authors:  Simona Ultimo; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2018-03-30

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

  9 in total
  1 in total

1.  Is relaxation exercise therapy effective in the management of patients with severe arterial hypertension?

Authors:  Olga D Lebedeva; Abduahat A Achilov; Zilola F Mavlyanova; Alexey V Baranov; Shachnosa A Achilova; Natalia P Sanina; Anatoly D Fesyun; Andrey P Rachin; Maxim Yu Yakovlev; Kirill V Terentev; Igor V Reverchuk; Alie S Velilyaeva; Maria Chiara Maccarone; Stefano Masiero
Journal:  Eur J Transl Myol       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.